Advertisement

Die Einsatzmöglichkeiten der hochauflösenden Kernspin-Spektroskopie und Histotomographie bei Tumoren und Metastasen

  • O. Haferkamp
Chapter

Zusammenfassung

Die Kernspin-Spektroskopie des Blutes ist ein Verfahren, deren diagnostische Möglichkeiten in den gegenwärtigen Untersuchungen ausgelotet wird. Hoffnungen ergeben sich vor allem im Hinblick auf die Krebsfrühdiagnostik einschließlich der frühzeitigen Erkennung von Metastasen und Rezidiven. Die noch nicht gelöste Kernfrage dabei ist, wie spezifisch die aus dem Blut von Tumorpatienten gewonnenen Befunde sind. Noch nicht ganz so weit in der Entwicklung befindet sich die Kernspin-Histotomographie, bei der die Technik erst ausreifen muß. Die Arbeit geht nicht nur auf den Status quo dieser beiden zukunftsträchtigen Untersuchungsverfahren ein, sondern vermittelt auch deren wissenschaftliche Grundlagen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Aguajo JB, Blackband SJ, Schoeninger J, Mattingly MA, Hintermann M (1986) Nuclear magnetic resonance imaging of a single cell. Nature 322:190–191CrossRefGoogle Scholar
  2. 2.
    Bottomley PA, Hardy CJ, Argersinger RE, Allen-Moore G (1987) A review of 1H nuclear magnetic resonance relaxation in pathology: Are T1 and T2 diagnostic? Med Phys 14:1–37PubMedCrossRefGoogle Scholar
  3. 3.
    Bydder GM, Brown J, Niendorf HP, Young IR (1985) Enhancement of cervical intraspinal tumors in NMR imaging with intravenous gadolinium-DTPA. J Comput Assist To-mogr 9:847–851CrossRefGoogle Scholar
  4. 4.
    De Certaines J, Moulinoux JP, Benoist L, Bernard A-M, Rivet P (1982) Proton nuclear magnetic resonance of regenerating rat liver after partial hepatectomy. Life Sci 31:505–508PubMedCrossRefGoogle Scholar
  5. 5.
    Damadian R, Zaner K, Hor D, DiMaio R (1974) Human tumors detected by nuclear magnetic resonance. Proc Natl Acad Sci USA 71:1471–1473PubMedCrossRefGoogle Scholar
  6. 6.
    Degani H, Horowitz A, Itzchak Y (1986) Breast tumors: evaluation with P-31 MR spectroscopy. Radiology 161:53–55PubMedGoogle Scholar
  7. 7.
    Dennis JW, Laferté S, Fukuda M, Dell A, Carver JP (1986) Asn-linked oligosaccharides in lectin-resistant tumor-cell mutants with varying metastatic potential. Eur J Biochem 161:359–373PubMedCrossRefGoogle Scholar
  8. 8.
    Fossei ET, Carr JM, McDonagh J (1986) Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. N Engl Med 315:1369–1376CrossRefGoogle Scholar
  9. 9.
    Ganssen A (1986) MR-Imaging and spectroscopy offering new possibilities in medical diagnoses. Axenrod T, Ceccarelli G (eds) NMR in living systems. D Reidel Publishing Co., Dordrecht, pp 177–191CrossRefGoogle Scholar
  10. 10.
    Hazlewood CF, Cleveland G, Medina D (1974) Relationship between hydration and proton nuclear magnetic resonance relaxation times in tissues of tumorbearing and non-tumor-bearing mice: implications for cancer detection. J Natl. Cancer Inst 52:1849–1853PubMedGoogle Scholar
  11. 11.
    Inch WR, McCredie JA, Knispel RR, Thompson RT, Pintar MM (1974) Water content and proton spin relaxation time for neoplastic and non-neoplastic tissues from mice and humans. J Natl Cancer Inst 52:353–356PubMedGoogle Scholar
  12. 12.
    Itai Y, Ohtomo K, Fururi S, Minami M, Kohki Y, Yashiro N (1986) MR imaging of hepatocellular carcinoma. J Comput Assist Tomogr 10:963–968PubMedCrossRefGoogle Scholar
  13. 13.
    Kimmey MB, Silverstein FE, Haggit RC, Shuman WP, Mack LA, Rohrman CA, Moss AA, Franklin DW (1987) Cross-sectional imaging method a system to compare ultrasound, computed tomography, and magnetic resonance with histologic findings. Invest Radiol 22:227–231PubMedCrossRefGoogle Scholar
  14. 14.
    Kolata GB (1976) Water structure and ion binding: A role in cell physiology? Science 192:1220–1222PubMedCrossRefGoogle Scholar
  15. 15.
    Lauterbur PC (1973) Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature 242:190–191CrossRefGoogle Scholar
  16. 16.
    Ling CR, Forster MA, Mallard JR (1979) Changes in NMR relaxation times of adjacent muscle after implantation of malignant and normal tissue. Br J Cancer 40:898PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Mathur de Vré R, Grimée R, Rosa M (1983) Experimental protocol for tissue discrimination in vitro by n.m.r. Biosci Rep 3:599–608CrossRefGoogle Scholar
  18. 18.
    Morris PG (1986) Nuclear magnetic resonance imaging in medicine and biology. Clarence, OxfordGoogle Scholar
  19. 19.
    Mountford CE, Wright LC, Dyne M, May GL, Mackinnin WB, Holmes KT, Haaften-Day C van, Tattersall MHN (1986) Classification of human tumours by high-resolution magnetic resonance spectroscopy. Lancet 4:829–833Google Scholar
  20. 20.
    Oberhaensli RD, Bore PJ, Rampling RP, Hilton-Jones D, Hands LJ, Radda GK (1986) Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy. Lancet 5:8–11CrossRefGoogle Scholar
  21. 21.
    Parl FF, Harris TM (1987) Detection of malignant tumors by nuclear magnetic resonance spectroscopy of plasma. N Engl J Med 316:1411–1412CrossRefGoogle Scholar
  22. 22.
    Quay SC, Comess K, Worah D, Gandhi R (1986) Proton nuclear magnetic resonance studies in diagnostic surgical pathology. Lab Invest 54:51 AGoogle Scholar
  23. 23.
    Ranade SS (1987) Cell type and proton relaxation. Invest Radiol 22:346–347PubMedCrossRefGoogle Scholar
  24. 24.
    Ranney DF (1987) New Method uses Magnetic Resonance Imaging. Tumor’s Response to Monitor directly the Effects of some Anticancer Drugs. Jama 257:3183–3184CrossRefGoogle Scholar
  25. 25.
    Reinig JW, Doppman JL, Dwyer AJ, Johnson AR, Knop RH (1985) Distinction between adrenal adenomas and metastases using MR imaging. J Comp Assist Tomogr 9:898–901CrossRefGoogle Scholar
  26. 26.
    Ross BD, Barker PB, Eley CGS, Schmidt PG, Roberts JD (1987) Letter to the editor. New Engl J Med 316:1412Google Scholar
  27. 27.
    Schein PS (1986) Oncolipids? A possible new approach to diagnosis of cancer. Editorial. N Engl J Med 315:1410–1411CrossRefGoogle Scholar
  28. 28.
    Small DM, Hamilton JA (1987) Letter to the editor. New Engl J Med 316:1412–1413Google Scholar
  29. 29.
    Wieczorek AJ, Rhyner C, Block LH (1985) Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans. Proc Natl Acad Sci USA 82:3455–3459PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • O. Haferkamp
    • 1
  1. 1.Institut für Pathologie und RechtsmedizinUniversität UlmUlmDeutschland

Personalised recommendations